Literature DB >> 27408990

Pembrolizumab: the value of PDL1 biomarker in head and neck cancer.

Raffaele Addeo1, Michele Caraglia2, Giada Iuliano3.   

Abstract

Entities:  

Keywords:  Head and neck cancer; human papilloma virus; immunotherapy; pembrolizumab; programmed cell death (PD-1)

Year:  2016        PMID： 27408990     DOI： 10.1080/14712598.2016.1211635

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN： 1471-2598            Impact factor:   4.388


× No keyword cloud information.
  6 in total

1.  High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.

Authors:  Stanton J Kochanek; David A Close; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2018-12-28       Impact factor: 1.738

2.  Maximizing the Value of Cancer Drug Screening in Multicellular Tumor Spheroid Cultures: A Case Study in Five Head and Neck Squamous Cell Carcinoma Cell Lines.

Authors:  Stanton J Kochanek; David A Close; Daniel P Camarco; Paul A Johnston
Journal:  SLAS Discov       Date:  2020-01-25       Impact factor: 3.341

3.  PD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: implications for anti-PD1 clinical trials.

Authors:  Angela M Hong; Ricardo E Vilain; Sarah Romanes; Jean Yang; Elizabeth Smith; Deanna Jones; Richard A Scolyer; C Soon Lee; Mei Zhang; Barbara Rose
Journal:  Oncotarget       Date:  2016-11-22

Review 4.  Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma.

Authors:  Paul Nghiem; Howard L Kaufman; Murtuza Bharmal; Lisa Mahnke; Hemant Phatak; Jürgen C Becker
Journal:  Future Oncol       Date:  2017-03-28       Impact factor: 3.404

5.  Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer.

Authors:  Haoyu Lyu; Mengyuan Li; Zehang Jiang; Zhixian Liu; Xiaosheng Wang
Journal:  Comput Struct Biotechnol J       Date:  2019-07-26       Impact factor: 7.271

6.  Tumor-Infiltrating Immune Cells and PD-L1 as Prognostic Biomarkers in Primary Esophageal Small Cell Carcinoma.

Authors:  Xiao Wu; Xiurong Ke; Yangpeng Ni; Liping Kuang; Fan Zhang; Yusheng Lin; Wan Lin; Xiao Xiong; Haihua Huang; Xianjie Lin; Hao Zhang
Journal:  J Immunol Res       Date:  2020-12-29       Impact factor: 4.818
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.